Summary

CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. Founded in 1916 as Commonwealth Serum Laboratories, CSL has grown to become the world's fifth largest biotechnology company with operations in over 35 countries. The company specializes in blood plasma derivatives, vaccines, antivenoms, and cell culture reagents used in medical and genetic research applications. CSL operates through several key divisions including CSL Behring (focusing on rare and serious diseases), CSL Seqirus (one of the world's largest influenza vaccine providers), CSL Plasma, and CSL Vifor. With over 32,000 employees globally, CSL maintains a strong R&D pipeline and has invested over US$3.3 billion in research and development over the past five years. The company is publicly traded on the Australian Securities Exchange and has its global headquarters in Parkville, Melbourne, Australia.

Job description

Responsibilities

Under general supervision, responsible for evaluating donor suitability for automated pheresis procedures
Provides limited emergency medical care to donors and staff including administering medication or treatments in accordance with licensure or certification
Interviews donors and performs medical history reviews to obtain necessary information to determine suitability to donate plasma
In conjunction with the Center Medical Director, responds to medically related questions and provides information to staff on donor suitability
Reviews test results and determines continued donor suitability; assesses donor symptoms that may result in the inability to continue donating
Notifies and counsels donors regarding reactive test results; refers donors to community facilities for follow-up and counseling
Provides routine care following Standard Operating Procedures (SOPs); escalates critical medical situations to Center Physician or local medical service providers as required

Qualifications

Graduation from a paramedic, nursing, physician assistant, chiropractic, medical school or naturopathic medical training program
If graduation is from a foreign allopathic or osteopathic medical school, must also currently be licensed as a physician or state certification as an emergency medical technician
For NY: current state licensure or certification as an RN, MD or DO in the state you are applying for work or in a reciprocal state
Minimum of one (1) year relevant experience in a health care environment
Experience in a plasma or whole blood collection center or other regulated environment preferred
Ability to make and analyze a physical assessment of heart, lung sounds, signs of drug use, etc.

Requirements

Graduation from a paramedic, nursing, physician assistant, chiropractic, medical school or naturopathic medical training program
If graduation is from a foreign allopathic or osteopathic medical school, must also currently be licensed as a physician or state certification as an emergency medical technician
For NY: current state licensure or certification as an RN, MD or DO in the state you are applying for work or in a reciprocal state
Minimum of one (1) year relevant experience in a health care environment
Experience in a plasma or whole blood collection center or other regulated environment preferred
Ability to make and analyze a physical assessment of heart, lung sounds, signs of drug use, etc.

Company overview

CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. Founded in 1916 as Commonwealth Serum Laboratories, CSL has grown to become the world's fifth largest biotechnology company with operations in over 35 countries. The company specializes in blood plasma derivatives, vaccines, antivenoms, and cell culture reagents used in medical and genetic research applications. CSL operates through several key divisions including CSL Behring (focusing on rare and serious diseases), CSL Seqirus (one of the world's largest influenza vaccine providers), CSL Plasma, and CSL Vifor. With over 32,000 employees globally, CSL maintains a strong R&D pipeline and has invested over US$3.3 billion in research and development over the past five years. The company is publicly traded on the Australian Securities Exchange and has its global headquarters in Parkville, Melbourne, Australia.